The medicines scheduling
delegate has confirmed the
interim decision recommended
by the TGA’s Advisory Committee
on Medicines Scheduling that
ranitidine (Zantac) be exempted
from Schedule 2 when in divided
preparations for oral use containing
300mg or less of ranitidine per
dosage unit, in the manufacturer’s
original pack containing not more
than seven dosage units.
The delegate has also confirmed
that esomeprazole (Nexium) will be
included in Appendix H.
The implementation date for the
changes is 01 Oct 2015.The above article was sent to subscribers in Pharmacy Daily's issue from 24 Jul 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Jul 15
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
AUSTRALIA’S public hospitals are facing their lengthiest wait times on record for planned surgeries, with emergency departments struggling under access blockages, according to the latest annual Public Hospital Report Card by the Australian Medical Association (AMA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.